SmPC - Mometasone Furoate 1mg/g Ointment: Change history
View Summary of Product Characteristics (SmPC - Mometasone Furoate 1mg/g Ointment)
Last updated on this site: 10 Mar 2025
IAIN, C.I.3.a - To update section 4.8 of the SmPC in line with the MHRA request SA 19259594 for topical mometasone and ADR rosacea. Consequently, the PIL has been updated.
SmPC sections updated: 4.8 and 10.
Last updated on this site: 10 Mar 2025
IAIN, C.I.3.a - To update section 4.8 of the SmPC in line with the MHRA request SA 19259594 for topical mometasone and ADR rosacea. Consequently, the PIL has been updated.
SmPC sections updated: 4.8 and 10.
-
Changes: (Updated: 10 Mar 2025)
IAIN, C.I.3.a - To update section 4.8 of the SmPC in line with the MHRA request SA 19259594 for topical mometasone and ADR rosacea. Consequently, the PIL has been updated.
SmPC sections updated: 4.8 and 10.
-
Changes: (Updated: 05 Sep 2024)
To update sections 4.4 of the SPC to bring in line with the MHRA request to update potency labelling of topical corticosteroids. Consequentially, the leaflet (PIL) and labelling are updated.
-
Changes: (Updated: 06 Dec 2023)
Description of update: To update sections 4.4 and 5.1 of the SmPC and the PIL in line with MHRA letter to include the topical corticosteroid potency as defined by the ATC code. Additionally, minor amends have been made to the PIL to correct spelling and grammar.
SmPC Sections updated: 4.4, 5.1 and 10.
-
Changes: (Updated: 21 Sep 2022)
Initial upload